MicroInvasive Glaucoma Surgery (MIGS) Where To Next?
Iqbal Ike K. Ahmed, MD, FRCSC, asks surgeons to comment on what excites them about the future of minimally invasive glaucoma surgery (MIGS). Mark J. Gallardo, MD; Nathan M. Radcliffe, MD; I. Paul Singh, MD; Mahmoud A. Khaimi, MD; and David Richardson, MD, discuss MIGS devices in the pipeline and explain how these procedures improve the quality of life for both patients and physicians.
Ab Interno Canaloplasty (ABiC™) In The Spotlight
Iqbal Ike K. Ahmed, MD, FRCSC, asks a group of experts featuring Mark J. Gallardo, MD; Nathan M. Radcliffe, MD; Mahmoud A. Khaimi, MD; David Richardson, MD; and I. Paul Singh, MD, to address the misconceptions and barriers to adoption for ab interno canaloplasty (ABiC). The group explains how ABiC iTrack (Ellex) compares to other minimally invasive glaucoma surgery (MIGS) procedures.
MicroInvasive Glaucoma Surgery (MIGS) In Daily Practice
Iqbal Ike K. Ahmed, MD, FRCSC, opens up discussion on preferred minimally invasive glaucoma surgery (MIGS) procedures. Mark J. Gallardo, MD; I. Paul Singh, MD; Mahmoud A. Khaimi, MD; David Richardson, MD; and Nathan M. Radcliffe, MD, each describe their approach to MIGS and discuss the mechanism of action of ABiC iTrack (Ellex).
Interventional Glaucoma: SLT AND MIGS
At ASCRS 2018 in Washington, DC, a group of surgeons experienced in interventional glaucoma therapies sat down to discuss the roles of selective laser trabeculoplasty (SLT) and microinvasive glaucoma surgery (MIGS) for treatment of open angle glaucoma (OAG).
Ab-Interno Canaloplasty: Two-Year Results
[Photo Credit: www.augencentrumkoeln.de] Not everyone with glaucoma is excited about having an implant (however small) permanently placed in the eye. Additionally, not everyone with glaucoma has a cataract. Unfortunately, all current FDA approved minimally invasive...Why I Will NOT be Implanting the CyPass® into my Younger Patients with Glaucoma
Image Source: Medgadget via https://youtu.be/8oAjFQwqgnM 08.29.2018 NEWS UPDATE: Alcon announces voluntary global market withdrawal of CyPass Micro-Stent for surgical glaucoma | SOURCE:...“Gentler” yet Effective Glaucoma Surgeries
Most glaucoma surgeons agree that Minimally Invasive Glaucoma Surgery (MIGS) Procedures are “gentler” than trabeculectomy or glaucoma drainage devices. MIGS Procedures are faster, done through very small corneal incisions, and have fewer risks. However,...Who Will Likely Benefit from the Stegmann Canal Expander®?
Who Will Likely Benefit from the Stegmann Canal Expander®? Most anyone who is a candidate for canaloplasty should also benefit from placement of the Stegmann Canal Expander®. At the time of this writing, however, only those outside of the USA can do so as the FDA has...Comparison to Canaloplasty without the Stegmann Canal Expander®
When the results of this study are compared to the results of prior long-term studies of Canaloplasty glaucoma surgery, use of the Stegmann Canal Expander® appears to provide an additional 3mmHg of IOP lowering effect.2 Source: Canal Expander | Canal Expander...
